08048035996
Cancer UJVIRA 100mg Injection trusted to Canada - Toronto | Phoenix Exim | Global Exporter

1. General Information

UJVIRA 100 mg Injection belongs to the antineoplastic/targeted cancer therapy class. Its active ingredient, trastuzumab emtansine, combines a HER2-targeting monoclonal antibody with a chemotherapy component. This allows the medicine to target HER2-expressing cancer cells and deliver the cytotoxic component to them.

It is a prescription-only medicine and should be administered by qualified healthcare professionals in an appropriate clinical setting.

2. Product Information

  • Brand: UJVIRA 100 mg Injection
  • Active ingredient: Trastuzumab emtansine
  • Strength: 100 mg
  • Dosage form: Powder for injection / injectable formulation
  • Therapeutic class: Antineoplastic / targeted cancer therapy
  • Manufacturer: Zydus
  • Route: Intravenous administration by a healthcare professional
  • Storage: Generally refrigerated at 2°C–8°C; do not freeze.
  • Prescription: Required

3. Uses of UJVIRA 100 mg Injection

UJVIRA is used for selected HER2-positive cancers, including:

  • HER2-positive breast cancer
  • Certain advanced or metastatic HER2-positive breast cancers
  • HER2-positive gastric or gastroesophageal-junction cancers, depending on the treatment indication and local approval
  • Certain patients whose cancer has progressed or returned following previous HER2-directed treatment.

The exact indication depends on the patient's HER2 status, previous treatment, disease stage, and the prescribing oncologist's treatment plan.

4. Benefits of UJVIRA 100 mg Injection

The potential benefits of trastuzumab emtansine include:

  • Targeted cancer treatment: The trastuzumab component recognizes HER2 receptors on cancer cells.
  • Directed drug delivery: The emtansine component is delivered to HER2-expressing cells.
  • Inhibition of cancer-cell growth: The treatment can interfere with cancer-cell survival and proliferation.
  • Useful in selected previously treated patients: It can be an important treatment option for certain HER2-positive cancers after previous therapy.

Treatment benefits vary considerably between patients and should be assessed by an oncologist.

5. Side Effects of UJVIRA 100 mg Injection

UJVIRA may cause side effects. Some reactions can be serious and require prompt medical attention.

Possible adverse effects include:

  • Low platelet count
  • Anemia
  • Nausea or vomiting
  • Diarrhea
  • Fatigue
  • Headache
  • Peripheral neuropathy
  • Hair loss
  • Fever or chills
  • Bleeding or nosebleeds
  • Liver enzyme abnormalities
  • Infusion-related or hypersensitivity reactions
  • Heart-function abnormalities
  • Lung-related toxicity in rare cases.

Seek immediate medical attention for severe breathing difficulty, significant allergic reactions, unusual bleeding, severe weakness, or symptoms suggestive of heart or lung problems.

6. Common Side Effects

Frequently reported or clinically important side effects may include:

  • Nausea
  • Fatigue
  • Headache
  • Diarrhea
  • Vomiting
  • Muscle or joint pain
  • Low blood-cell counts
  • Peripheral neuropathy
  • Nosebleeds
  • Hair loss
  • Increased liver enzymes.

Not every patient experiences these effects, and their severity can vary.

7. How to Use UJVIRA 100 mg Injection

UJVIRA should not be self-administered.

It is prepared and administered by a qualified healthcare professional, generally through an intravenous infusion. The dose and treatment interval are determined by the oncologist according to factors such as body weight, cancer type, treatment history, response, and tolerance.

Patients should:

  1. Follow the oncologist's prescribed schedule.
  2. Attend required blood tests and medical monitoring.
  3. Report unusual bleeding, severe fatigue, fever, numbness, breathing problems, or other significant symptoms.
  4. Never change the dose or treatment interval without medical advice.

8. How UJVIRA 100 mg Injection Works

UJVIRA contains trastuzumab emtansine, an antibody-drug conjugate.

The trastuzumab component attaches to the HER2 receptor found in increased amounts on certain cancer cells. After binding to HER2, the conjugate is taken into the cancer cell, where the emtansine component interferes with microtubule function and helps prevent cell division. This targeted mechanism helps destroy or inhibit HER2-positive cancer cells.

9. Safety Advice

  • Prescription use: Use only under an oncologist's supervision.
  • Pregnancy: UJVIRA can cause fetal harm. Women who could become pregnant should discuss effective contraception with their healthcare provider.
  • Breastfeeding: Breastfeeding is generally not recommended during treatment; discuss this with the treating physician.
  • Heart conditions: Tell your doctor about previous heart disease or reduced heart function because trastuzumab-based therapy can affect cardiac function.
  • Liver disease: Inform your doctor about liver problems and undergo recommended liver-function monitoring.
  • Lung problems: Report new or worsening cough, shortness of breath, or breathing difficulties.
  • Bleeding: Low platelet counts can increase bleeding risk, so report unusual bruising or bleeding.
  • Allergies: Inform the healthcare provider about previous reactions to trastuzumab, emtansine, or related medicines.
  • Storage: Keep refrigerated at 2°C–8°C and do not freeze. Follow the product's approved storage and handling instructions.

10. FAQs

Q1. What is UJVIRA 100 mg Injection used for?
It is used for selected HER2-positive cancers, particularly certain forms of breast cancer.

Q2. What is the active ingredient in UJVIRA?
The active ingredient is trastuzumab emtansine.

Q3. Is UJVIRA a chemotherapy medicine?
It is an antibody-drug conjugate, combining targeted HER2 therapy with a cytotoxic chemotherapy component.

Q4. Can I inject UJVIRA myself?
No. It should be prepared and administered by appropriately trained healthcare professionals.

Q5. Does UJVIRA require refrigeration?
Yes. Product information specifies refrigerated storage, generally at 2°C–8°C, and it should not be frozen.

Q6. Can UJVIRA be used for HER2-negative cancer?
It is intended for cancers with the appropriate HER2 expression. HER2 status should be confirmed by appropriate testing before treatment.

Q7. Can UJVIRA affect the heart?
Yes. Cardiac function can be affected, so doctors may perform heart-function assessments before and during treatment.

Q8. What should I do if I miss an infusion?
Contact your oncology team. Do not attempt to compensate for a missed dose yourself.

Q9. Can UJVIRA be used during pregnancy?
It may harm the developing fetus and therefore requires careful medical assessment and effective pregnancy prevention.

Q10. Is UJVIRA available for international supply?
International pharmaceutical supply is subject to the importing country's prescription, registration, customs, and regulatory requirements. Buyers should verify local requirements before ordering.

11. Substitute for UJVIRA 100 mg Injection

The appropriate substitute depends on the active ingredient, indication, strength, treatment protocol, and regulatory availability. Products containing trastuzumab emtansine may be considered as alternatives where approved and clinically appropriate.

Some oncology references also list Kadcyla as a related alternative; however, it is important to note that substitute selection should be made by the treating oncologist rather than by changing brands independently.

Important: Do not replace UJVIRA with another trastuzumab-containing or HER2-targeted medicine without medical approval, because trastuzumab, trastuzumab emtansine, and other HER2 therapies are not automatically interchangeable.

12. SEO Keywords

Primary keywords:

  • Ujvira 100mg Injection
  • Ujvira 100 mg Injection
  • Ujvira 100mg Injection exporter
  • Ujvira 100mg Injection supplier
  • Ujvira 100mg Injection manufacturer
  • Ujvira 100mg Injection from India
  • Trastuzumab Emtansine 100mg Injection
  • Trastuzumab Emtansine Injection exporter
  • Trastuzumab Emtansine supplier India
  • HER2 positive breast cancer injection

Long-tail B2B keywords:

  • Buy Ujvira 100mg Injection from India
  • Ujvira 100mg Injection pharmaceutical exporter India
  • Ujvira 100mg Injection supplier from Nagpur India
  • Ujvira 100mg Injection wholesale pharmaceutical supplier
  • Genuine Ujvira 100mg Injection exporter from India
  • Ujvira 100mg Injection international pharmaceutical supplier
  • Trastuzumab Emtansine 100mg Injection supplier India
  • Trastuzumab Emtansine 100mg Injection exporter from India
  • Ujvira 100mg Injection for international pharmaceutical supply
  • Ujvira 100mg Injection supplier for USA and UK
  • Ujvira 100mg Injection supplier for Australia and Canada
  • Ujvira 100mg Injection supplier for Singapore and UAE
  • Ujvira 100mg Injection supplier for South Korea
  • HER2 positive breast cancer medicine exporter India
  • Anti-cancer medicine exporter from Nagpur India
Aug 21st, 2026 3:59 PM

Keywords